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Objective: The purpose of this study is to investigate if the Danish national diagnosis-related 
group (DRG) tariffs for surgery for abdominal aortic aneurysm (AAA) were good estimates of 
the actual costs in two local hospitals in the Central Region of Denmark.
Methods: We collected clinical data for 178 AAA patients operated at Skejby Hospital and 
Viborg Hospital in the period 2005–2006 from the Danish National Vascular Registry and 
economic data from the administrative systems in the hospitals. We used bootstrap methods 
to calculate 95% confidence intervals (CIs) for the mean costs of surgery for ruptured AAA, 
nonruptured AAA and AAA where the patient died within 30 days by applying a cost-trimming 
rule that the Danish National Board of Health uses in calculating national DRG tariffs.
Results: The national DRG tariff lies within the calculated Danish Krone (DKK) CIs (CI rup-
tured AAA, 98,178–195,327 [€13,196–€26,254]; CI nonruptured AAA, 79,039–98,178 
[€10,624–€13,196]; CI dead, 42,023–111,685 [€5,648–€15,011]), and thus national DRG tariffs 
could be a good estimate for the actual costs in the local hospitals.
Conclusion: The bootstrap method is useful for testing the generalizability of national DRG 
tariffs as estimates of local surgical costs.
Keywords: bootstrap method, costs, DRG, abdominal aortic aneurysm
Introduction
National diagnosis-related group (DRG) tariffs are the basis for reimbursement of 
  inpatient hospital costs in many countries.1–3 In Denmark, the DRG tariffs are recal-
culated each year by the Danish National Board of Health by applying a full-cost 
accounting principle to the Danish DRG case-mix based on detailed reports of costs and 
activities from 31 hospitals responsible for approximately 60% of hospital discharges 
in Denmark. The DRG tariffs are calculated as the mean costs for all activities in the 
respective DRGs and used as a central tool for reimbursement and decision making 
in the Danish health care system. Because of the financial implications, the validity 
and generalizability of the national DRG tariffs are often questioned, and continuous 
analyses of the appropriateness of the tariffs are warranted.1–4
The purpose of this study is to use the bootstrap method to perform tests of 
the   generalizability of national DRG tariffs with respect to local setting. We 
chose the case of surgery for abdominal aortic aneurysms (AAAs) as an empirical 
example because the DRG tariffs for AAA surgery have been fluctuating since the 
introduction of the Danish DRG system in 2002, and a number of health economic ClinicoEconomics and Outcomes Research 2010:2 submit your manuscript | www.dovepress.com
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Table 1 Descriptive statistics of patients operated for abdominal 
aortic aneurysm
Mean Standard 
deviation
Median Range N
Ruptured
iCU 6.29 7.52 4 39 31
general ward 11.83 9.55 10 37 31
Theatre usage 2.00 0.60 2 2.5 31
nonruptured
iCU 2.80 2.81 2 17 117
general ward 10.20 5.52 9 40 117
Theatre usage 2.37 0.82 2.37 4.8 117
Dead
iCU 3.73 5.63 1 20 30
general ward 3.76 5.32 1 18 30
Theatre usage 2.11 1.19 1.95 4.04 30
Total
iCU 3.56 4.65 2 39 178
general ward 9.40 6.85 8 41 178
Theatre usage 2.26 0.87 2.17 4.84 178
Note: Time in intensive care unit (iCU) and general ward are measured in days. 
Theatre usage is measured in hours.
studies in this field have questioned the appropriateness of 
using national DRG rates as proxies for surgical costs.5–7 
We, therefore, performed tests to investigate if the Danish 
DRG reimbursement rates for surgery for AAA were a good 
estimate for the actual costs of AAA surgery in the Central 
Region of Denmark in 2005–2006.
Materials and methods
Patient data
Our dataset consisted of 178 male patients having experienced 
ruptured or nonruptured AAA in the period 2005–2006. No 
data on surgical technique were available. In 2006, endo-
vascular AAA surgery was approximately 10% of all AAA 
surgery in Denmark. Mortality rates in both hospitals were 
similar to national averages for rupture and elective surgery. 
The mean age of these patients was 71.37 years. The descrip-
tive statistics of the patient group is presented in Table 1.
The patients were operated at one of the two hospitals 
in the Central Region of Denmark with a cardiovascular 
surgery unit, Viborg Hospital (86/178) and Skejby Hospital 
(92/178). Of the 178 patients, 31 (17%) had experienced a 
rupture, 117 (66%) underwent surgery for a nonruptured 
aneurysm, and 30 (17%) were registered as dead. Patients 
were registered as dead if they had died within 30 days after 
surgery for AAA.
We obtained data for theatre usage and total length of stay 
from the Danish Vascular Surgery Registry. Data for hours in 
intensive care unit (ICU) were obtained from the statistical 
departments in the local hospitals.
Cost data
A microcosting approach4,8 was used to calculate the total 
average cost for surgery for ruptured AAA, nonruptured 
AAA, and death in close collaboration with the economic 
departments in the hospitals. Special attention was given 
to the risk of double-counting and omitting cost items. We 
calculated the costs per patient as the sum of the costs of 
theatre usage, costs of stay at the ICU, and costs of stay in 
the general ward. This has been shown to be the main cost 
drivers of surgery for AAA.9,10 Information on unit cost 
was calculated from the management accounting systems 
at the hospitals. Costs were calculated including overhead 
in 2006 prices.
Calculations of the total average  
costs per patient
The total average cost per patient was calculated as the sum 
of the following three main cost drivers, which adds up to 
the costs included in the DRG tariffs:
1.  Cost of theatre usage: The total cost per patient was cal-
culated as the sum of the labor costs (the average number 
of hours in theatre times and the average wage rate per 
hour for each participant in the theatre) and calculated 
overhead costs. The hourly labor cost was estimated for 
surgeons, nurses, and others as actual wages including 
pension assuming approximately 1,700 effective work-
ing hours per year. Assumptions used to estimate theatre 
staff in procedures were obtained through literature and 
interviews. The overhead costs were calculated accord-
ing to the type of patient, ie, ruptured AAA, nonruptured 
AAA, and death. We excluded certain types of overhead 
costs (the hotel costs) in this calculation of the cost of 
theatre usage in order to avoid double-counting.
2.  Cost of stay at the ICU: The total costs per patient were 
calculated as the cost per day times the number of days 
in ICU. The costs per day in ICU were obtained from the 
management accounting systems in the hospitals.
3.  Length of stay in general ward: The total costs per patient 
were calculated as the cost per day times the number 
of days in general wards. The costs per day in general 
ward unit were obtained from the hospital management 
accounting systems.
The Danish DRg system
A new Danish case-mix system including DRGs for   inpatient 
services was implemented in Denmark in 2002.11,12 The system 
is widely used for reimbursement and as a tool for analyz-
ing costs and activities in the Danish health care   sector. ClinicoEconomics and Outcomes Research 2010:2 submit your manuscript | www.dovepress.com
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Like any other case-mix system, hospital services are grouped 
into resource homogenous groups, and tariffs are calculated 
for each group to represent the average total cost of the 
services within the particular group. The Danish case-mix 
system consists of 599 DRG tariffs and 93 Danish Ambula-
tory Group System (DAGS) tariffs (2006 version). A DRG/
DAGS tariff is defined as an average per diem or case-mix 
group cost for an activity belonging to a resource homoge-
neous group. It is the intention of the case-mix system that 
each tariff should reflect the average costs of treating a typical 
patient belonging to the particular group. (DAGS is used for 
ambulatory patients defined as patients treated in an ambula-
tory department, whereas DRG is used for inpatient treatment 
defined as patients treated in a bed department). In principle, 
a DRG/DAGS tariff includes all hospital costs needed to per-
form an activity from this group, ie, both variable costs, such 
as labor and materials, and fixed overhead costs. However, 
depreciation and financial interests on buildings, civil servant 
pensions, and some research expenses are excluded.
The tariffs are updated by the National Board of Health each 
year based on detailed reports of costs and activities from the 
participating hospitals. The report produced by each hospital 
includes a step-wise allocation of all hospital costs to final cost 
centers (whose output can be linked to patient contacts). The 
costs at the nonclinical overhead departments are allocated to 
the other overhead departments and after that to the final cost 
centers. This allocation is based on national guidelines and 
entails fixed or prioritized allocation bases for overhead.
The Danish DRG system divides AAA patients into 
three different DRG groups: ruptured, nonruptured, and 
dead. The DRG tariffs in Danish Krone (DKK) for these 
three groups were 108,554 DKK (ruptured), 88,016 DKK 
(nonruptured) and 48,588 DKK (dead) in 2006.7
Tests
We performed two statistical tests of the hypothesis that 
our calculated costs equal the DRG rates. Due to the 
skewed nature of the cost data, we decided to apply simple 
bootstrap methods13,14 to construct 95% confidence inter-
vals (CIs). This procedure has the advantage that we do 
not have to make any distributional assumptions, and it 
has been recommended as the primary statistical test for 
making inferences about arithmetic means for small-sized 
samples of skewed cost data.13 The bootstrap method is 
based on repeated sampling from the observed data to cal-
culate nonparametric CIs (we used 1,000 replicates). We 
also performed a Student’s t-test based on 95% confidence 
limits for comparison purposes.
Finally, we applied the trimming rule from the Danish 
DRG system on our data and performed the same tests again. 
Trimming the data means changing the value of outliers to 
a certain maximum. In the Danish DRG system, outliers 
are defined as observations outside the 95% quartile and 
these observations are given the value of the 95% quartile. 
The trimming point is 20 bed days for ruptured AAA, 
33 days for nonruptured AAA, and 1 day for death. All 
tests were carried out using Stata 9.0 (StataCorp, College 
Station, TX).
Results
The costs of theatre usage in the two hospitals are presented 
in Table 2. It is seen that the two hospitals differ a great 
deal with respect to overhead costs. This reflects the fact 
that Skejby Hospital is equipped with more sophisticated 
  technology, ie, more capital intensive. This is also indicated in 
the costs per stay in ICU, where the costs for Skejby Hospital 
and Viborg Hospital were 16,037 DKK and 13,892 DKK 
per day, respectively. The costs per day in the general ward 
were 4,345 DKK and 3,414 DKK for Skejby Hospital and 
Viborg Hospital, respectively.
The results of the calculation of total average costs per 
patient are shown in Table 3. It is seen that there is a large 
difference between the mean and the medians for all groups; 
this merely illustrates that the cost data are right-skewed. The 
skewed data, caused by some extreme values, give rise to 
high standard deviations.
The results of the statistical test of whether the Danish 
DRG tariffs were a good estimate of the actual costs of sur-
gery for AAA in the Central Region of Denmark are shown 
in Table 4.
From the bootstrap intervals, it is observed that 
three DRG tariffs lie within the 95% CI (CI ruptured AAA, 
98,178–195,327 [€13,196–€26,254]; CI nonruptured AAA, 
79,039–98,178 [€10,624–€13,196]; CI dead, 42,023–111,685 
[€5,648–€15,011]). This means that we cannot reject equality 
between our estimates and the DRG tariffs. The t-statistics 
for the dead, nonruptured, and ruptured patients were 1.50, 
0.11, and 1.52, respectively. Hence, with a significance level 
Table 2 Cost per hour of theatre usage (DKK per hour)
Overhead cost Labor cost
Skejby 
hospital
Viborg 
hospital
Skejby 
hospital
Viborg 
hospital
Rupture 1,241 623 1,973 1,921
nonrupture 1,446 783 2,293 2,412
Death 1,344 703 2,132 2,166ClinicoEconomics and Outcomes Research 2010:2 submit your manuscript | www.dovepress.com
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Table 3 Costs of surgery for abdominal aortic aneurysm (costs in DKK)
Mean Standard deviation Median Range N
Nontrimmed Trimmed Nontrimmed Trimmed Nontrimmed Trimmed Nontrimmed Trimmed
Ruptured 146,717 138,557 138,940 105,116 116,008 116,008 753,025 500,060 31
nonruptured 88,609 82,298 55,636 32,979 72,642 72,642 389,764 132,828 117
Dead 76,854 69,306 102,744 81,991 25,613 25,613 388,338 255,555 30
Table 4 Confidence intervals with significance level of 5% (costs in DKK)
Lower bound Upper bound DRG
Parametric Nonparametric Parametric Nonparametric
nontrimmed
Ruptured 95,754 98,178 197,681 195,327 108,544
nonruptured 78,421 79,039 98,796 98,178 88,016
Dead 38,488 42,023 115,219 111,685 48,588
Trimmed
Ruptured 100,000 102,355 177,114 174,759 108,544
nonruptured 76,259 76,129 88,336 88,466 88,016
Dead 38,690 41,345 99,922 97,268 48,588
Abbreviation: DRg, diagnostic-related group.
of 5%, we could not reject equality between our estimates 
and the DRG rates.
Even though our aim was not to replicate the DRG rates, 
we must be aware of the fact that the Danish DRG system 
labels observations outside the 95% quartile as outliers and 
gives these observations the value of the 95% quartile. It 
is seen from Table 4 that by trimming our data in the same 
fashion as the Danish DRG system, we get slightly differ-
ent CIs; however, our conclusions do not change because 
the DRG rates still fall within the CIs. By using Student’s 
t-test, we got t-statistics of 1.38 (dead), 1.58 (ruptured), 
and 1.87 (nonruptured), and hence this could not reject 
our hypothesis of equality. Since our conclusions do not 
change, our tests are robust to the effect that large values 
might have.
Discussion
Our objective was to use the bootstrap method to test whether 
the national DRG tariffs were good estimates of the real or 
observed average costs associated with treatment of AAA in 
two local Danish hospitals. We carried out simple tests based 
on the bootstrap method to investigate whether our estimates 
could be equal to the DRG tariffs, and our results showed 
that the estimates we get from our cost data could not be said 
to be different from the national DRG tariffs. Although the 
DRG tariffs have been fluctuating, the variation in tariffs in 
the period 2005–2007 has been within the bootstrap intervals. 
Hence, the DRG tariffs at first seem to be an appropriate 
measure of the cost associated with AAA.
However, before concluding on these results, three 
points must be taken into consideration. First, it is seen 
that the variation in the costs per operation is quite large. 
This is primarily due to patient-specific circumstances. 
The broad CIs should not be a result of relatively few 
observations in the sample if the empirical distribution of 
the sample data is an adequate representation of the true 
distribution of the costs of AAA surgery. This we cannot 
be sure of. Second, the national DRG tariffs for rupture 
and death do in several instances lie at the border of our 
CIs; however, changing the confidence level to 90% does 
not lead to rejection of equality between our estimates 
and the DRG estimates. Third, the costs differ at the two 
hospitals, and the conclusion from the tests might not 
apply to the hospitals alone.
We used bootstrap methods to make inferences about the 
mean of the skewed cost data as recommended by Desgagne 
et al,13 and we applied to our sample the same trimming rules 
that have been used by the Danish National Board of Health 
in calculating the national DRG tariffs.7
Compared with other nonparametric tests of median 
costs, such as Wilcoxon style rank tests, the bootstrap method 
preserves the economically important characteristics of the 
data.13 We also applied normal Student’s t-test for compari-
son purposes; however, due to the skewness of our cost data 
and the relatively small amount of observations, the results 
derived from this procedure could be inferior to the bootstrap 
results. The Student’s t-test has advantages; however, its 
limitations are known to most readers.ClinicoEconomics and Outcomes Research
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As more countries adopt or adapt DRG-type case 
  classification systems, decision makers and researchers are 
becoming increasingly reliant on national DRG tariffs.15–17 
Yet, such tariffs do not necessarily reflect costs in different 
local settings, even when the clinical condition or procedure 
category appears similar. Furthermore, national DRG-type 
systems are not identical and are not utilized for the same 
purpose. Therefore, statistical tests of the generalizability of 
national reimbursement rates may be relevant to perform in 
many instances. We believe our study could serve as a rel-
evant input or inspiration for decision makers and economic 
researchers in other settings who might want to investigate 
whether national reimbursement rates are good estimates of 
local costs.
Conclusion
The bootstrap method was applied to test the generalizability 
of national reimbursement rates with respect to local setting. 
Danish national DRG rates were found to be a good estimate 
of the costs of surgery for AAA in the Central Region of 
Denmark during the years 2005–2006.
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